aspirin has been researched along with digoxin in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (32.39) | 18.7374 |
1990's | 12 (16.90) | 18.2507 |
2000's | 20 (28.17) | 29.6817 |
2010's | 16 (22.54) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Romankiewicz, JA | 1 |
Heidrich, H | 1 |
Elfving, SM; Elonen, E; Neuvonen, PJ | 1 |
Craft, AW; Nicholson, A | 1 |
Watson, AD | 1 |
Sharma, SN | 1 |
Atkins, CE; Keene, BW; Snyder, PS | 1 |
Baar, S; Jackson, D; Pollock, A; Sevitt, S; Stone, P | 1 |
Jick, H | 1 |
Naess, K | 1 |
Costello, JM; Shannon, FT | 1 |
Eldredge, WJ; McCue, CM; Noble, A; Robertson, LW | 1 |
Greene, W | 1 |
Wilcke, JR | 1 |
Furst, DE | 1 |
Bornstein, A; Dalal, P; Michaelson, S; Novack, S; Tischler, J | 1 |
Parry, EH | 1 |
Calvert, CA; Thrall, DE | 1 |
Comess, KA; Fenster, PE; Finley, PR; Hanson, CD | 1 |
Halawa, B; Mazurek, W | 1 |
Doll, R; Skegg, DC | 1 |
Compostella, L; Nascimben, L; Prandoni, P; Russo, R; Schivazappa, L | 1 |
Massing, GK; Mockridge, PB; Wilkerson, RD | 1 |
Giles, TD | 1 |
Dunn, FG; Lip, GY; Tean, KN | 1 |
Blackshear, JL; Hammill, SC; Kopecky, SL; Litin, SC; Safford, RE | 1 |
Ebly, E; Hachinski, V; Hogan, D; Rockwood, K | 1 |
Agius-Muscat, H; Azzopardi, J; Fava, S | 1 |
Berrón-Perez, R; Huicochea-Grobet, Z; Larenas-Linnemann, DE; Onuma-Takane, E; Ortega-Martell, JA | 1 |
Gibbs, NM; Mahon, BD; Newman, MA; Sheminant, MR; Weightman, WM; Whitford, EG | 1 |
Braatvedt, GD; Gamble, GD; Persson, S; Singh, Y; Stewart, FM | 1 |
Cornell, ES; Heckbert, SR; Psaty, BM; Smith, NL; Tracy, RP | 1 |
Ashton, CM; Baker, DW; Dunbar, SB; Friesinger, GC; Havranek, EP; Hlatky, MA; Konstam, M; Krumholz, HM; Ordin, DL; Pina, IL; Pitt, B; Spertus, JA | 1 |
Rossi, G | 1 |
McKelvie, R | 3 |
STICKLER, GB | 1 |
Faulkner, MA; Lenz, NJ; Lenz, TL | 1 |
Bolling, SF; Geltz, A; Spoor, MT | 1 |
Enlund, H; Hartikainen, SA; Hiitola, PK; Sulkava, RO | 1 |
Bennett, K; Feely, J; Mahmud, A; Okechukwu, I | 1 |
Byrne, S; Gallagher, P; Kennedy, J; O'Mahony, D; Ryan, C | 1 |
Al-Khatib, SM; Allen Lapointe, NM; d'Almada, P; Kaplan, S; Sun, JL | 1 |
Doane, CJ; Gigliotti, A; Lammey, ML; Lee, DR; Sleeper, MM | 1 |
Julka, M; Paruchuri, R; Rao, S | 1 |
Bhagra, S; Eurich, DT; Jhund, PS; Lewsey, JD; MacDonald, MR; Majumdar, SR; McAlister, FA; McMurray, JJ; Petrie, JR; Petrie, MC | 1 |
Al-Khatib, SM; Blazing, MA; Califf, RM; Kong, MH; O'Connor, C; Shaw, LK | 1 |
Chen, WY; Holmes, MD | 1 |
Inoue, Y | 1 |
Bhattarai, D; Choi, Y; Hyeon Han, S; Jang, Y; Lee, K; Singh, S | 1 |
Cato-Varlack, J; Gaffney, J; Kernizan, D | 1 |
Borek-Dohalska, L; Fojtikova, V; Martinkova, M; Mináriková, M; Sedláček, J; Šikut, M; Stiborová, M; Vyskočilová, E | 1 |
Ahern, TP; Christiansen, P; Cronin-Fenton, D; Damkier, P; Ejlertsen, B; Lash, TL; Sørensen, HT | 1 |
Fu, S; Luo, L; Ping, P; Ye, P | 1 |
15 review(s) available for aspirin and digoxin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Bioavailability and bioinequivalence of drug formulations in small animals.
Topics: Animals; Aspirin; Biological Availability; Cats; Chloramphenicol; Digoxin; Dogs; Fenbendazole; Mitotane; Oxytetracycline; Penicillins; Phenytoin; Theophylline; Therapeutic Equivalency; Thyroxine | 1992 |
Drug interactions involving cimetidine--mechanisms, documentation, implications.
Topics: Acetaminophen; Adrenergic beta-Antagonists; Analgesics, Opioid; Animals; Antacids; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Anticoagulants; Anticonvulsants; Antifungal Agents; Aspirin; Benzodiazepines; Cimetidine; Digoxin; Drug Interactions; Humans; Intestinal Absorption; Iron; Lidocaine; Pancreas; Phenytoin; Prednisolone; Theophylline; Vitamin B 12 | 1984 |
Idiosyncracies of drug metabolism in cats. Effects on pharmacotherapeutics in feline practice.
Topics: Acetaminophen; Animals; Aspirin; Benzyl Alcohol; Benzyl Alcohols; Biotransformation; Cats; Digoxin; Glucuronates; Liver; Morphine; Pharmaceutical Preparations; Species Specificity; Veterinary Medicine | 1984 |
Optimizing the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume | 1994 |
Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Anti-Arrhythmia Agents; Aspirin; Atrial Fibrillation; Catheter Ablation; Cerebrovascular Disorders; Diabetes Complications; Digoxin; Diltiazem; Embolism; Humans; Hypertension; Thromboembolism; Verapamil; Warfarin | 1996 |
[Congestive heart failure in the elderly: specific aspects].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Cardiotonic Agents; Clinical Trials as Topic; Diastole; Digoxin; Diuretics; Drug Interactions; Echocardiography; Electrocardiography; Fibrinolytic Agents; Heart Failure; Humans; Platelet Aggregation Inhibitors; Radiography, Thoracic; Systole; Ventricular Dysfunction | 2000 |
Heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Defibrillators, Implantable; Digoxin; Exercise; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Warfarin | 2003 |
Potential interactions between exercise and drug therapy.
Topics: Absorption; Acetaminophen; Adrenergic beta-Antagonists; Aspirin; Digoxin; Doxycycline; Exercise; Humans; Insulin; Pharmacokinetics; Theophylline; Tissue Distribution; Verapamil; Warfarin | 2004 |
Heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Defibrillators, Implantable; Digoxin; Exercise; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Spironolactone; Warfarin | 2004 |
Heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Cardiotonic Agents; Defibrillators, Implantable; Digoxin; Exercise; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Spironolactone; Warfarin | 2004 |
Pharmaceutical drug overdose.
Topics: Acetaminophen; Adrenergic beta-Antagonists; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Aspirin; Benzodiazepines; Calcium Channel Blockers; Charcoal; Digoxin; Drug Overdose; Gastric Lavage; Humans; Ipecac; Practice Guidelines as Topic; Renal Dialysis | 2006 |
Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Digoxin; Drug Repositioning; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Off-Label Use | 2012 |
[Blood concentration useful in the diagnosis and treatment of poisoning].
Topics: Acetaminophen; Aspirin; Barbiturates; Digoxin; Drug Monitoring; Humans; Inorganic Chemicals; Lithium; Organic Chemicals; Pesticides; Poisoning; Theophylline | 2014 |
An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
Topics: Antineoplastic Agents; Aspirin; Digoxin; Diphosphonates; Drug Approval; Drug Discovery; Drug Repositioning; Humans; Itraconazole; Metformin; Nelfinavir; Thalidomide | 2016 |
1 trial(s) available for aspirin and digoxin
Article | Year |
---|---|
Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.
Topics: Adult; Aspirin; Charcoal; Depression, Chemical; Digoxin; Female; Humans; Intestinal Absorption; Male; Phenytoin; Salicylates | 1978 |
55 other study(ies) available for aspirin and digoxin
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effects of antacids on gastrointestinal absorption of drugs.
Topics: Animals; Antacids; Aspirin; Chlordiazepoxide; Chlorpromazine; Dicumarol; Digitoxin; Digoxin; Ephedrine; Guinea Pigs; Humans; Intestinal Absorption; Iron; Isoniazid; Levodopa; Naproxen; Pentobarbital; Pharmaceutical Preparations; Quinidine; Quinine; Rats; Sulfadiazine; Tetracyclines; Warfarin | 1976 |
[Conservative therapy of peripheral arterial occlusive diseases. Possibilities and basic principles].
Topics: Arterial Occlusive Diseases; Aspirin; Coumarins; Dextrans; Digoxin; Exercise Therapy; Humans; Vasodilator Agents | 1978 |
[Medicines in young children].
Topics: Aspirin; Child; Digoxin; Drug-Related Side Effects and Adverse Reactions; Humans; Iron; Penicillins; Phenobarbital | 1978 |
The management of poisoning in children.
Topics: Alcoholic Intoxication; Antidepressive Agents, Tricyclic; Aspirin; Atropine; Child; Digoxin; Household Products; Humans; Iron; Poisoning | 1975 |
Atrial flutter in myocardial infarction.
Topics: Aspirin; Atrial Flutter; Digoxin; Electrocardiography; Furosemide; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Oxygen Inhalation Therapy | 1992 |
Effect of aspirin, furosemide, and commercial low-salt diet on digoxin pharmacokinetic properties in clinically normal cats.
Topics: Administration, Oral; Animals; Aspirin; Cats; Diet, Sodium-Restricted; Digoxin; Drug Combinations; Female; Furosemide; Male | 1988 |
Acute Heinz-body anaemia in burned patients.
Topics: Adult; Ampicillin; Anemia, Hemolytic; Aspirin; Burns; Carbenicillin; Cloxacillin; Digoxin; Erythrocytes; Female; Gentamicins; Glucosephosphate Dehydrogenase; Heinz Bodies; Humans; Infant; Male; Probenecid; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections | 1973 |
Drugs--remarkably nontoxic.
Topics: Adult; Aspirin; Boston; Digoxin; Drug Evaluation; Drug Therapy; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Hospitalization; Humans; Statistics as Topic; United States | 1974 |
[Dose and concentration. Not always proportional].
Topics: Aspirin; Biopharmaceutics; Digoxin; Dose-Response Relationship, Drug; Humans | 1973 |
Drugs and children.
Topics: Aminophylline; Aspirin; Atropine; Cardiomyopathies; Cataract; Child, Preschool; Chloramphenicol; Chlorothiazide; Conjunctivitis; Digoxin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Iatrogenic Disease; Infant; Infant, Newborn; Infant, Newborn, Diseases; Male; Ophthalmic Solutions; Pre-Eclampsia; Pregnancy; Purpura, Thrombocytopenic; Substance-Related Disorders; Suppositories | 1968 |
Acute rheumatic fever in Virginia--has it changed in the last 20 years?
Topics: Acute Disease; Adult; Aspirin; Child; Demography; Digoxin; Female; Hospitalization; Humans; Male; Penicillin G Benzathine; Penicillins; Phenobarbital; Rheumatic Fever; Rheumatic Heart Disease; Socioeconomic Factors; Steroids; Streptococcus; Sulfadiazine; Virginia | 1970 |
Use of ibuprofen in unusual circumstances.
Topics: Arthritis, Rheumatoid; Aspirin; Bartter Syndrome; Cyclooxygenase Inhibitors; Digoxin; Drug Hypersensitivity; Drug Interactions; Ductus Arteriosus, Patent; Humans; Ibuprofen; Indomethacin; Kidney; Kinetics; Lithium; Liver; Lupus Erythematosus, Systemic; Mixed Connective Tissue Disease; Phenytoin; Platelet Aggregation; Prostaglandins E; Warfarin | 1984 |
Acute myocardial infarction in a thirty-six year old postpartum female.
Topics: Adult; Aspirin; Digoxin; Electrocardiography; Ergonovine; Female; Heart Aneurysm; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nifedipine; Pregnancy; Puerperal Disorders | 1984 |
Management of rheumatic heart disease in tropical countries.
Topics: Adolescent; Adult; Aspirin; Child; Child, Preschool; Costs and Cost Analysis; Digoxin; Diuretics; Emergencies; Female; Humans; Male; Mitral Valve Stenosis; Myocarditis; Penicillin G Benzathine; Prednisone; Premedication; Pulmonary Edema; Rheumatic Heart Disease; Tropical Climate | 1983 |
Treatment of canine heartworm disease coexisting with right-side heart failure.
Topics: Animals; Aspirin; Digoxin; Dirofilariasis; Dog Diseases; Dogs; Furosemide; Heart Failure; Rest | 1982 |
Kinetics of the digoxin-aspirin combination.
Topics: Adult; Animals; Aspirin; Creatinine; Digoxin; Dogs; Drug Interactions; Female; Humans; Kinetics; Male; Middle Aged | 1982 |
[Interactions of digoxin and the nonsteroidal anti-inflammatory drugs, acetylsalicylic acid and nifedipine].
Topics: Adult; Arthritis; Aspirin; Coronary Disease; Digoxin; Drug Interactions; Humans; Indomethacin; Male; Middle Aged; Neuritis; Nifedipine; Phenylbutazone; Pyridines | 1982 |
Record linkage for drug monitoring.
Topics: Aged; Aspirin; Cerebral Hemorrhage; Computers; Delivery, Obstetric; Diarrhea; Digoxin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Medical Record Linkage; Medical Records; Mortality; Patient Admission; Pregnancy | 1981 |
[ST-segment trend in patients with acute myocardial infarction treated with antithrombotic drugs (author's transl)].
Topics: Aged; Aspirin; Digoxin; Diuretics; Electrocardiography; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Nitro Compounds; Oxygen Inhalation Therapy | 1981 |
Effects of selected drugs on serum digoxin concentration in dogs.
Topics: Acetaminophen; Animals; Aspirin; Digoxin; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Female; Ibuprofen; Indomethacin; Male; Metabolic Clearance Rate; Quinidine; Quinine; Time Factors | 1980 |
[Drug interactions in therapy of cardiac decompensation].
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Digoxin; Diuretics; Drug Interactions; Heart Failure; Histamine H2 Antagonists; Humans; Sulfinpyrazone | 1994 |
Treatment of atrial fibrillation in a district general hospital.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Digoxin; Echocardiography; Electric Countershock; Emergencies; Female; Hospitalization; Humans; Length of Stay; Male; Medical Audit; Middle Aged; Scotland; Thyroid Function Tests; Warfarin | 1994 |
Presence and treatment of vascular risk factors in patients with vascular cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspirin; Cognition Disorders; Dementia; Diabetes Complications; Diabetes Mellitus; Digoxin; Female; Humans; Hypertension; Male; Risk Factors; Vascular Diseases | 1997 |
Outcome of unstable angina in patients with diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Unstable; Angioplasty; Aspirin; Calcium Channel Blockers; Case-Control Studies; Confidence Intervals; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Diabetic Angiopathies; Digoxin; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Nitrates; Prospective Studies; Risk Factors; Time Factors | 1997 |
Treacher-Collins syndrome and co-existing dermatomyositis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiotonic Agents; Child, Preschool; Dermatomyositis; Digoxin; Female; Humans; Mandibulofacial Dysostosis; Prednisone; Skin | 1998 |
Drug therapy before coronary artery surgery: nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Cardiotonic Agents; Cerebrovascular Disorders; Chronic Disease; Coronary Artery Bypass; Coronary Disease; Creatinine; Diabetes Complications; Digoxin; Female; Fibrinolytic Agents; Forecasting; Hemoglobins; Hospital Mortality; Humans; Hypertension; Logistic Models; Lung Diseases; Male; Middle Aged; Myocardial Infarction; Nitrates; Reoperation; Risk Factors; Sex Factors; Survival Rate; Ventricular Function, Left; Warfarin | 1999 |
Atrial fibrillation: prevalence and management in an acute general medical unit.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Digoxin; Electric Countershock; Female; Humans; Male; Middle Aged; New Zealand; Patient Admission; Platelet Aggregation Inhibitors; Prospective Studies; Thromboembolism; Warfarin | 1999 |
The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly.
Topics: Aged; Aspirin; Cardiovascular Agents; Digoxin; Humans; Hydrochlorothiazide; Patient Compliance; Propranolol; Reproducibility of Results | 1999 |
Evaluating quality of care for patients with heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Atrial Fibrillation; Data Collection; Digoxin; Exercise Therapy; Fee-for-Service Plans; Heart Failure; Humans; Information Services; Length of Stay; Outcome and Process Assessment, Health Care; Patient Education as Topic; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quality of Health Care; Referral and Consultation; Stroke Volume; United States; Ventricular Dysfunction, Left | 2000 |
DRUG DOSAGE. A REVIEW OF A PROBLEM IN PEDIATRICS.
Topics: Aspirin; Child; Digitoxin; Digoxin; Dosage Forms; Drug Therapy; Humans; Infant; Pediatrics; Phenobarbital; Phenytoin; Sulfadiazine; Thyroid Hormones | 1964 |
Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiomyopathy, Dilated; Combined Modality Therapy; Databases, Factual; Digoxin; Diuretics; Drug Therapy, Combination; Equipment Design; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Heart-Assist Devices; Humans; Male; Middle Aged; Milrinone; Mitral Valve; Mitral Valve Insufficiency; Norepinephrine; Pliability; Postoperative Complications; Prospective Studies; Recurrence; Reoperation; Spironolactone; Stroke Volume; Time Factors; Tricuspid Valve Insufficiency; Ultrasonography | 2006 |
Changes in the use of cardiovascular medicines in the elderly aged 75 years or older--a population-based Kuopio 75+ study.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agents; Cohort Studies; Digoxin; Diuretics; Drug Utilization; Finland; Homebound Persons; Humans; Hypertension; Institutionalization; Nitrates; Survivors; Time Factors; Warfarin | 2007 |
National underuse of anti-thrombotic therapy in chronic atrial fibrillation identified from digoxin prescribing.
Topics: Age Factors; Aged; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Cyclooxygenase Inhibitors; Digoxin; Female; Humans; Male; Middle Aged; Sex Factors; Thrombosis; Treatment Outcome; Warfarin | 2007 |
STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.
Topics: Abbreviations as Topic; Age Factors; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bendroflumethiazide; Clopidogrel; Delphi Technique; Digoxin; Diuretics; Drug Prescriptions; Drug Therapy; Drug Utilization Review; Drug-Related Side Effects and Adverse Reactions; Glomerular Filtration Rate; Health Services for the Aged; Humans; Ireland; Metformin; Practice Patterns, Physicians'; Reproducibility of Results; Risk Factors; Ticlopidine; Time Factors; United Kingdom | 2008 |
Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Catheter Ablation; Digoxin; Drug Utilization; Electric Countershock; Female; Hospitalization; Humans; Male; Medicine; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Severity of Illness Index; Specialization; United States; Warfarin; Wolff-Parkinson-White Syndrome | 2008 |
Diagnosis and treatment of pulmonary arterial hypertension and atrial fibrillation in an adult chimpanzee (Pan troglodytes).
Topics: Animals; Antihypertensive Agents; Aspirin; Atrial Fibrillation; Cardiotonic Agents; Digoxin; Diuretics; Enalapril; Furosemide; Hypertension, Pulmonary; Liver; Lung; Male; Myocardium; Pan troglodytes; Platelet Aggregation Inhibitors; Primate Diseases | 2008 |
Atrial fibrillation: Ways to refine your care.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Calcium Channel Blockers; Digoxin; Echocardiography, Transesophageal; Electric Countershock; Electrocardiography; Humans; Lung; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Radiography; Warfarin | 2009 |
Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Case-Control Studies; Diabetes Mellitus, Type 2; Digoxin; Female; Heart Failure; Humans; Hypoglycemic Agents; Male; Metformin; United Kingdom | 2010 |
Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Calcium Channel Blockers; Digoxin; Diuretics; Female; Heart Failure, Diastolic; Heart Rate; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Warfarin | 2010 |
Prolonged Fevers in a Previously Healthy Child.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiotonic Agents; Child, Preschool; Digoxin; Female; Fever; Heart Failure; Humans; Myocarditis; Rheumatic Fever | 2017 |
The capacity and effectiveness of diosmectite and charcoal in trapping the compounds causing the most frequent intoxications in acute medicine: A comparative study.
Topics: Adsorption; Alpha-Amanitin; Amlodipine; Antidotes; Aspirin; Carbamazepine; Charcoal; Digoxin; Ibuprofen; Imipramine; Oxazepam; Phenobarbital; Poisoning; Promethazine; Silicates; Theophylline | 2017 |
Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database.
Topics: Adrenergic beta-Antagonists; Analgesics, Opioid; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Cardiotonic Agents; Cyclooxygenase 2 Inhibitors; Databases, Factual; Denmark; Digoxin; Disease Progression; Estrogen Antagonists; Female; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neoplasm Recurrence, Local; Platelet Aggregation Inhibitors; Prognosis; Selective Serotonin Reuptake Inhibitors; Simvastatin; Tamoxifen | 2018 |
Relationship between drug application and mortality rate in Chinese older coronary artery disease/chronic heart failure patients with and without low glomerular filtration rate.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Asian People; Aspirin; Calcium Channel Blockers; Clopidogrel; Coronary Artery Disease; Digoxin; Drug Utilization; Female; Glomerular Filtration Rate; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nitrates | 2019 |